e-Drug3D

1664

M TAZAROTENE


INN
TAZAROTENE

(is an active metabolite)

cas 118292-41-4
CLASS

DERMATOLOGIC AGENTS
KERATOLYTIC AGENTS
PRODRUGS
TERATOGENS
RETINOIDS

ROUTE (list)

-

ATC code

D05AX05
D05AX55

PK parameters

PPB 99 PERCENT
t1/2 18 HOUR

Target

TARGET RETINOIC ACID RECEPTOR GAMMA
RETINOIC ACID RECEPTOR BETA
RETINOIC ACID RECEPTOR ALPHA

DrugCentral

Retinoic acid receptor alpha UNIPROT P10276 RARA

Retinoic acid receptor beta UNIPROT P10826 RARB

Download SDF file 3-Pyridinecarboxylic acid, 6-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-

Formula:
C19H17NO2S

Calculated chemical properties:

MW 322.40
NB_atoms 23
XLogP 2.62
PSA 45.059
NB_HD 0
NB_HA 3
fsp3 0.26
Lipinski(0=no;1=yes) 1

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL